Starget Pharma

Ramat Hasharon, Israel Founded: 2019 • Age: 7 yrs
Targeted radiopharmaceuticals are developed for solid tumor treatment.
Request Access

About Starget Pharma

Starget Pharma is a company based in Ramat Hasharon (Israel) founded in 2019 by Ronen Kalmanson and Sigal Kalmanson Cusnir.. Starget Pharma has raised $15.1 million across 2 funding rounds from investors including Ilex Medical and Cancer Focus Fund. Starget Pharma offers products and services including Smart Targeted Radioligands and Peptides Backbone Dynamics Technology. Starget Pharma operates in a competitive market with competitors including RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and Leo Cancer Care, among others.

  • Headquarter Ramat Hasharon, Israel
  • Founders Ronen Kalmanson, Sigal Kalmanson Cusnir
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $15.1 M (USD)

    in 2 rounds

  • Latest Funding Round
    $5.1 M (USD), Series A

    Oct 31, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Starget Pharma

Starget Pharma offers a comprehensive portfolio of products and services, including Smart Targeted Radioligands and Peptides Backbone Dynamics Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Radioligands that deliver radiation to cancer cells with precision oncology focus.

Technology for designing peptide-based radioligands for cancer treatment.

People of Starget Pharma
Headcount 10-50
Employee Profiles 4
Employee Profiles
People
Mor Oron-Herman
Head Of Research And Development
People
Dr. Michel Afargan
Head Drug Developments & Radiopharmaceutical Strategies
People
Jacob Rendell
Scientific Operations & Data Integration

Unlock access to complete

Funding Insights of Starget Pharma

Starget Pharma has successfully raised a total of $15.1M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.1 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $5.1M
  • First Round

    (08 Dec 2021)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2024 Amount Series A - Starget Pharma Valuation

investors

Dec, 2021 Amount Series A - Starget Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Starget Pharma

Starget Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ilex Medical and Cancer Focus Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
An investment fund focused on oncology therapies is managed.
Founded Year Domain Location
Plastic injection molded components and wiring solutions are manufactured.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Starget Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Starget Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Starget Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Starget Pharma

Starget Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and Leo Cancer Care, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biology-guided radiotherapy systems are provided for cancer treatment.
domain founded_year HQ Location
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
domain founded_year HQ Location
Proton therapy systems are supplied for cancer radiation treatment.
domain founded_year HQ Location
Developer of gyroscopic radiosurgery platform
domain founded_year HQ Location
Advanced radiotherapy devices for cancer treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Starget Pharma

Frequently Asked Questions about Starget Pharma

When was Starget Pharma founded?

Starget Pharma was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Starget Pharma located?

Starget Pharma is headquartered in Ramat Hasharon, Israel. It is registered at Ramat Hasharon, Tel Aviv District, Israel.

Who is the current CEO of Starget Pharma?

Sigal Kalmanson Cusnir is the current CEO of Starget Pharma. They have also founded this company.

Is Starget Pharma a funded company?

Starget Pharma is a funded company, having raised a total of $15.1M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Dec 08, 2021.

What does Starget Pharma do?

Starget Pharma was founded in 2019 in Ramat Hasharon, Israel, within the radiopharmaceutical sector. Technologies for targeted delivery of radioactive isotopes to solid tumors are developed for cancer diagnosis and therapy. Molecules are researched as vectors to enable precise transfer of isotopes to cancerous sites. Operations focus on advancing these innovations for clinical applications in oncology.

Who are the top competitors of Starget Pharma?

Starget Pharma's top competitors include RefleXion, Alpha Tau Medical and ABK Biomedical.

What products or services does Starget Pharma offer?

Starget Pharma offers Smart Targeted Radioligands and Peptides Backbone Dynamics Technology.

Who are Starget Pharma's investors?

Starget Pharma has 2 investors. Key investors include Ilex Medical, and Cancer Focus Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available